Compass Therapeutics, Inc. announced that Stephen Squinto, Ph.D., a member of the Board of Directors, notified the Company of his resignation from the Board and all committees thereof, effective August 31, 2022. Dr. Squinto has been a member of the Board since 2015, when he joined representing an early investor in the Company and he is now moving on to pursue other professional endeavors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -5.00% | +4.09% | -26.60% |
28/05 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
28/05 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.60% | 17Cr | |
+15.96% | 12TCr | |
+19.48% | 11TCr | |
+18.95% | 2.65TCr | |
-24.10% | 1.94TCr | |
-19.03% | 1.62TCr | |
-21.01% | 1.54TCr | |
-46.14% | 1.52TCr | |
+64.02% | 1.49TCr | |
+4.35% | 1.35TCr |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Compass Therapeutics, Inc. Announces Resignation of Stephen Squinto as Member of the Board of Directors, Effective August 31, 2022